LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,017,000 | +22.9% | 39,535 | +23.4% | 0.00% | 0.0% |
| Q3 2016 | $3,269,000 | -15.5% | 32,026 | -1.3% | 0.00% | 0.0% |
| Q2 2016 | $3,870,000 | +38.8% | 32,441 | +24.5% | 0.00% | 0.0% |
| Q1 2016 | $2,789,000 | -4.0% | 26,049 | -2.8% | 0.00% | 0.0% |
| Q4 2015 | $2,905,000 | +35.2% | 26,788 | +6.8% | 0.00% | +100.0% |
| Q3 2015 | $2,148,000 | -19.9% | 25,076 | -5.6% | 0.00% | 0.0% |
| Q2 2015 | $2,680,000 | +52.2% | 26,557 | +16.3% | 0.00% | 0.0% |
| Q1 2015 | $1,761,000 | +16.1% | 22,827 | -19.9% | 0.00% | 0.0% |
| Q4 2014 | $1,517,000 | +147.9% | 28,500 | +118.8% | 0.00% | – |
| Q3 2014 | $612,000 | -43.5% | 13,023 | -25.1% | 0.00% | -100.0% |
| Q2 2014 | $1,083,000 | -33.2% | 17,389 | -27.9% | 0.00% | 0.0% |
| Q1 2014 | $1,622,000 | +7.3% | 24,112 | -16.1% | 0.00% | 0.0% |
| Q4 2013 | $1,511,000 | +392.2% | 28,748 | +305.5% | 0.00% | – |
| Q3 2013 | $307,000 | +631.0% | 7,090 | +530.2% | 0.00% | – |
| Q2 2013 | $42,000 | – | 1,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |